Aphria adds to planned portfolio of vapes & concentrates with PAX Labs agreement

Aphria Inc. (“Aphria” or the “Company“) (TSX: APHA and NYSE: APHA) today announced an agreement with San Francisco-based PAX Labs, Inc. (“PAX“), a leader in the…

Aphria Inc. (“Aphria” or the “Company“) (TSX: APHA and NYSE: APHA) today announced an agreement with San Francisco-based PAX Labs, Inc. (“PAX“), a leader in the design and development of premium cannabis vaporization devices, that will enable Aphria to provide premium cannabis extracts in pods designed for use with PAX’s innovative Era device and platform. The […]

The post Aphria adds to planned portfolio of vapes & concentrates with PAX Labs agreement appeared first on Technical420.

Leave a Reply

Your email address will not be published. Required fields are marked *